People: Nuvo Research Inc. (NRI.TO)

NRI.TO on Toronto Stock Exchange

0.25CAD
9 Feb 2010
Price Change (% chg)

$-0.01 (-5.77%)
Prev Close
$0.25
Open
--
Day's High
$0.26
Day's Low
$0.25
Volume
922,600
Avg. Vol
655,862
52-wk High
$0.54
52-wk Low
$0.12

view people for:

Summary

Name Age Since Current Position
Chicoine, Daniel 2009 Chairman of the Board, Co-Chief Executive Officer
London, John 2009 Vice Chairman of the Board, President, Co-Chief Executive Officer, Secretary
Moulds, James 2006 Chief Financial Officer, Vice President - Finance
Guntermann, Henrich 2009 President, Europe and Autoimmune Group, Director
Galer, Bradley 2009 President, Pain Group
Copeland, David 2006 Lead Director
Dobranowski, Anthony 2004 Director
Messier, Jacques 2004 Director
Von Lindeiner, Klaus 2004 Director
» Insider Trading

Biographies

Name Description
Chicoine, Daniel Mr. Daniel N. Chicoine, CA serves as Chairman of Nuvo Research Inc. Since 1982. He has benn appointed as Co-Chief Executive Officer of Nuvo Research Inc effective Dec. 1, 2009. Mr. Chicoine has held various positions at the Magna group of companies, including President and CEO of Atoma International Inc. While Mr. Chicoine was the CEO of Atoma, he succeeded in growing its business from $300 million per annum to $1 billion and effected a restructuring. In May 1994, Mr. Chicoine formed Triam Automotive Inc., an automobile parts supplier, with other former executives of Magna and, in July 1994, was instrumental in assisting the company in completing an initial public offering. While at Triam, he acted as Vice Chairman in charge of sales. After leaving Triam in 1996, Mr. Chicoine, along with two other former executives of Magna, formed Nighthawk Investments, a small investment company. Mr. Chicoine has also served as the President of PowerCart Systems Inc., a Markham-based private company that designs and manufactures battery-equipped workstations that power devices with wireless communication capability. Mr. Chicoine is a chartered accountant by profession.
London, John Mr. John C. London, LLB, LLM serves as Vice-Chairman and Secretary of Nuvo Research Inc. He has been appointed as President, Co-Chief Executive Officer of Nuvo Research Inc effective Dec. 1, 2009. He was Formerly President and Chief Executive Officer, Powercart Systems Inc. Mr. London is also a partner in Nighthawk Investments, which currently has ownership positions in two private companies, including Powercart. Prior to establishing Nighthawk with his partners in 1997, Mr. London was co-founder and Executive Vice-President of Triam Automotive Inc., which eventually became public and was subsequently sold to Magna International Inc. From 1988 to 1993, he was Executive Vice-President and General Counsel at Atoma International Inc., Magna's interior systems group. Prior to joining Magna, Mr. London was a partner with the Toronto law firm of Strathy, Archibald and Seagram (now Gowlings). Mr. London is a graduate of University of Western Ontario law school and holds a Masters of Law Degree from University College London.
Moulds, James Mr. James Moulds serves as Chief Financial Officer, Vice President - Finance of Nuvo Research Inc. He is responsible for overseeing the Company's overall financial activities and brings over 10 years of public company experience. Most recently he was the Senior Vice President, Finance for Tesma International Inc. ("Tesma"), a company listed on the TSX and NASDAQ, until it completed a "going private" transaction in 2005 and earlier had served in various capacities including Corporate Controller and Vice President, Finance and Treasurer. Mr. Moulds played an integral role on the executive management team that took Tesma public in 1995, growing its sales from $344 million to $1.7 billion in 2005 with operations on 4 continents. During his tenure he performed a key role in several public equity issues, debt financings, acquisitions and strategic planning. Prior to joining Tesma, Mr. Moulds worked in various financial capacities for Magna International Inc. and Ernst & Young LLP. Mr. Moulds holds a Master of Accounting from the University of Waterloo, where he also earned his undergraduate degree.
Guntermann, Henrich Dr. Henrich R.K. Guntermann, MD, MSc., has been appointed as President, Europe and Autoimmune Group of Nuvo Research Inc.He served as President, Chief Executive Officer of Nuvo Research Inc. Dr. Guntermann has more than 10 years of experience in the life sciences sector (including business development, restructuring and corporate financing). With a group of distinguished life sciences entrepreneurs, he founded BioAlliance AG, a German-based life sciences private equity and consulting firm. BioAlliance was formed to capitalize on the early stage development of the life sciences industry in the European Union, by developing life sciences companies and leveraging their technologies and products worldwide. Through its established international network, it brings together life sciences companies in the United States, Asia and Europe to foster growth through alliances. In addition, BioAlliance consults for international life sciences companies (pharmaceutical, medical devices, diagnostics and agro-biotech) in different stages of development, including large scale players in the life sciences sector and public institutions, such as city and state governments, the European Commission and the United Nations Industry Development Organization (UNIDO). Dr. Guntermann received his medical doctorate at the Philipps-University in Marburg, Germany. He also received a Masters of Science in Biology, with specialization in pharmacology/toxicology and human genetics.
Galer, Bradley Dr. Bradley Galer has been appointed as President, Pain Group of Nuvo Research Inc. He served as Vice President and General Manager of the Company's Pain Group.
Copeland, David Mr. David Copeland is Lead Independend Director of Nuvo Research Inc. He is a Chartered Accountant. He holds a Bachelor of Mathematics degree and has been the chief financial officer of a public Canadian company. He is Former President and Chief Operating Officer, Triam Automotive Inc., an automobile parts supplier. Prior to Triam, Mr. Copeland was Chief Financial Officer of Magna International Inc. and President and Chief Operating Officer of the Cosma Group of Magna. He is currently an active investor in early stage companies. His background includes practicing as a chartered accountant and a focus on business valuation and mergers and acquisitions.
Dobranowski, Anthony Mr. Anthony Dobranowski serves as Director of Nuvo Reesearch Inc. He is a Chartered Accountant. He holds a Bachelor of Science Degree, a Masters of Business Administration Degree and has been the chief financial officer and president of a public Canadian company. He is Vice President, Magna International Inc., a global automotive parts supplier. Previously, Mr. Dobranowski held positions as Vice Chairman, President, Executive Vice President and Chief Financial Officer of Tesma International Inc., a publicly traded Magna subsidiary. He was instrumental in the initial public offering of Tesma in 1995, and has been involved in all aspects of Tesma's growth, with particular emphasis on financing, investor relations and M&A activity. Previous to that, Mr. Dobranowski held various senior management positions with other Magna companies. Mr. Dobranowski holds an MBA from the University of Toronto and is also a chartered accountant.
Messier, Jacques Dr. Jacques Messier serves as Director of Nuvo Research Inc. He is Private business consultant. Most recently Dr. Messier was General Manager, The Semex Alliance, a partnership specializing in the development and marketing of high quality genetic technologies, products and services to benefit livestock producers around the world. Previously, Dr. Messier was involved in management consulting in a number of specialized assignments pulling from his experience from many different business sectors. From 1995 to 2001 Dr. Messier held various positions at Novopharm Ltd. a generic pharmaceutical company, including President and Chief Executive Officer. Dr. Messier was Chief Operating Officer of publicly-traded KV Pharmaceutical Company from 2001 to 2003. Dr. Messier has also held a variety of management positions with Agriculture Canada and Health Welfare, including the Director of the Bureau of Human Prescription Drugs. He started his career as a Doctor of Veterinary Medicine, and practiced large animal medicine at his veterinary clinic in Saskatchewan for six years before joining Agriculture Canada. Dr. Messier also holds an MBA from the University of Western Ontario.
Von Lindeiner, Klaus Dr. Klaus Von Lindeiner serves as Director of Nuvo Research Inc. He is Private business consultant. Prior to his retirement in 2000, Mr. von Lindeiner served as a senior executive for various European multinationals, including Wacker-Chemie GmbH, Lurgi GmbH and Metallgesellschaft AG. Previously, Mr. von Lindeiner worked as a legal advisor to the United Nations, Office of the High Commissioner for Refugees, as well as in the Organizational Committee for the 1972 Munich Olympic Games. He has served as a member of the regional advisory boards of Deutsche Bank AG, Allianz Insurance AG, and Dresdner Bank AG. He has also served as a director on the boards of GEFIU, Power Paper Ltd. and OXO Chemie AG. Currently, Mr. von Lindeiner serves as a member of the Advisory Board of Golding Capital Partners. Mr. von Lindeiner is a lawyer by profession with a doctorate in international law from the University of Geneva/Switzerland.

Basic Compensation

Name Fiscal Year Total
Chicoine, Daniel 358,750
London, John 358,750
Moulds, James 312,400
Guntermann, Henrich 358,750
Galer, Bradley --
Copeland, David --
Dobranowski, Anthony --
Messier, Jacques --
Von Lindeiner, Klaus --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Chicoine, Daniel 7,030,000 0
London, John 6,580,000 0
Moulds, James 1,333,333 96,000
Guntermann, Henrich 6,480,000 0
Galer, Bradley 0 0
Copeland, David 0 0
Dobranowski, Anthony 0 0
Messier, Jacques 0 0
Von Lindeiner, Klaus 0 0

Insider Trading

» Full list on Insider Trading
view people for: